Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
435 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03450967 | Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC | unknown | Phase 2 | 31 | Samsung Medical CenterOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT04932343 | Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor | unknown | — | 20 | Samsung Medical CenterOTHER | 1 | Jun 21, 2021 | clinicaltrials |
| NCT03052478 |
| Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression |
| completed |
| Phase 2 |
| 10 |
| Samsung Medical CenterOTHER |
| 1 |
| Jun 8, 2021 |
| clinicaltrials |
| NCT03791034 | Cell Free DNA for the Diagnosis and Treatment in Early NSCLC | recruiting | — | 700 | Samsung Medical CenterOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT01066234 | Adjuvant CCRT vs CT in Minimal N2 NSCLC | completed | Phase 2 | 17 | Samsung Medical CenterOTHER | 1 | Mar 22, 2021 | clinicaltrials |
| NCT01126008 | Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer | completed | Phase 2 | 44 | Samsung Medical CenterOTHER | 1 | Mar 22, 2021 | clinicaltrials |
| NCT03858582 | neoadjuvant_thymic Epithelial Tumor | unknown | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Mar 22, 2021 | clinicaltrials |
| NCT02299622 | Personalized Sequence for Thoracic, Esophageal, and H&N Cancer | unknown | — | 200 | Samsung Medical CenterOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT02593019 | Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients | completed | Phase 2 | 24 | Samsung Medical CenterOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT02747953 | Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib | completed | Phase 2 | 50 | Samsung Medical CenterOTHER | 0 | Mar 19, 2021 | clinicaltrials |
| NCT03215537 | Development of Patient Tailored Guideline of Physical Activity for Lung Cancer | unknown | N/A | 176 | Samsung Medical CenterOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04800978 | Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 0 | Mar 16, 2021 | clinicaltrials |
| NCT04777604 | Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using Organoid | unknown | — | 300 | Samsung Medical CenterOTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT03009682 | Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations(SUKSES-B) | completed | Phase 2 | 15 | Samsung Medical CenterOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03428607 | Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2] | completed | Phase 2 | 26 | Samsung Medical CenterOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03758729 | Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma. | withdrawn | Phase 2 | 0 | Samsung Medical CenterOTHER | 0 | Feb 16, 2021 | clinicaltrials |
| NCT04736043 | Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid | unknown | — | 300 | Samsung Medical CenterOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT04675008 | Central Nervous System(CNS) Efficacy of Dacomitinib | unknown | Phase 2 | 30 | Samsung Medical CenterOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT03377400 | Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer | unknown | Phase 2 | 40 | Samsung Medical CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03987815 | Neoadjuvant Nivolumab for Operable Esophageal Carcinoma | unknown | Phase 2 | 20 | Samsung Medical CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03254004 | Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cm | unknown | Phase 2 | 70 | Samsung Medical CenterOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT01823068 | Vandetanib in Advanced NSCLC With RET Rearrangement | completed | Phase 2 | 17 | Samsung Medical CenterOTHER | 1 | Dec 7, 2020 | clinicaltrials |
| NCT04607473 | ABUS for Early-stage Breast Cancer | unknown | N/A | 675 | Samsung Medical CenterOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT03487133 | Bortezomib/Dexamethasone Therapy in Patients With Relapsed and/or Refractory Cutaneous T-cell Lymphoma | completed | Phase 2 | 32 | Samsung Medical CenterOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT01965977 | Bortezomib Maintenance in High Risk DLBCL(Borma) | unknown | Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT02445404 | Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL | unknown | Phase 2 | 134 | Samsung Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT02544425 | VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)(VIDL+ASCT) | unknown | Phase 2 | 27 | Samsung Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT02670616 | Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma | completed | Phase 2 | 24 | Samsung Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT03730740 | Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma(Lemon-T) | unknown | Phase 2 | 79 | Samsung Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT04061850 | Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma(MCLRR) | completed | — | 88 | Samsung Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT02691351 | Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study | completed | — | 500 | Samsung Medical CenterOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT03974971 | Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean Population.(KBPDCN) | completed | — | 36 | Samsung Medical CenterOTHER | 1 | Sep 3, 2020 | clinicaltrials |
| NCT02607631 | A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor | completed | Phase 2 | 33 | Samsung Medical CenterOTHER | 0 | Jul 9, 2020 | clinicaltrials |
| NCT02544997 | A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway | completed | Phase 2 | 5 | Samsung Medical CenterOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT04429633 | Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer | unknown | N/A | 136 | Samsung Medical CenterOTHER | 1 | Jun 12, 2020 | clinicaltrials |
| NCT04368442 | Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation(BRCAm) | unknown | — | 583 | Samsung Medical CenterOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT04247633 | High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx) | unknown | Phase 2 | 578 | Samsung Medical CenterOTHER | 1 | Apr 20, 2020 | clinicaltrials |
| NCT01761461 | Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial(ARTIST-II) | unknown | Phase 3 | 547 | Samsung Medical CenterOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT02161822 | Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients | unknown | Phase 2 | 60 | Samsung Medical CenterOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT00798811 | High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors | unknown | Phase 2 | 100 | Samsung Medical CenterOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT01963117 | Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis | terminated | N/A | 11 | Samsung Medical CenterOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT02638428 | Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy | unknown | Phase 2 | 90 | Samsung Medical CenterOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT02784054 | Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor | unknown | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT03977623 | Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression(COGET-B) | unknown | — | 200 | Samsung Medical CenterOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT04127916 | Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL) | unknown | — | 40 | Samsung Medical CenterOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT03585998 | Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer | unknown | Phase 2 | 51 | Samsung Medical CenterOTHER | 1 | Mar 2, 2020 | clinicaltrials |
| NCT04276337 | Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy | unknown | — | 50 | Samsung Medical CenterOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT04258735 | Genetic Characteristics of Metastatic Breast Cancer Patients | unknown | N/A | 300 | Samsung Medical CenterOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT03782896 | The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery | completed | — | 89 | Samsung Medical CenterOTHER | 1 | Jan 31, 2020 | clinicaltrials |
| NCT04187716 | Intravenous Iron Injection in Cancer Patients With Anemia | unknown | Phase 3 | 341 | Samsung Medical CenterOTHER | 1 | Jan 22, 2020 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials